FDA Drug recall D-0299-2022
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404,…
- FDA Drug
- Class I
- terminated
- Published 2022-01-05
On 2022-01-05 the FDA classified a Class I recall of Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404,… by Gilead Sciences, citing presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0299-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-12-03 |
| Published | 2022-01-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Gilead Sciences |
| Distribution | US |
Product
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Reason
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Identifiers
| ndc | 61958-2902-2 |
|---|---|
| ndc | 61958-2901-2 |
| code_info | Lots: 2141001-1A, 2141002-1A, Exp. 01/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0299-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.